Skip to main content
. 2013 Nov 23;17(2):173–182. doi: 10.3109/13697137.2013.834493

Table 1.

Subject demographic and baseline clinical characteristics (intent-to-treat population). Data are given as mean ± standard deviation or n (%)

Variable Ospemifene 60 mg/day Placebo
Number randomized to treatment 363 63
Age (years) 61.7 ± 6.2 62.9 ± 6.5
Body mass index (kg/m2) 24.7 ± 2.9 24.1 ± 2.9
Race
White 361 (99.4%) 63 (100%)
Black 1 (0.3%) 0 (0%)
Asian 1 (0.3%) 0 (0%)